Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah H Chung

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Annals of the Rheumatic Diseases|August 3, 2021
Correspondence on "SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response" by Bonelli <i>et al</i>Sarah H Chung, Mark Wener, Alison M Bays, et al.
Journal for Immunotherapy of Cancer|June 16, 2023
Selective immune suppression using interleukin-6 receptor inhibitors for management of immune-related adverse eventsFaisal Fa'ak, Maryam Buni, Adewunmi Falohun, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Annals of the Rheumatic Diseases|August 3, 2021
Correspondence on "SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response" by Bonelli <i>et al</i>Sarah H Chung, Mark Wener, Alison M Bays, et al.
Journal for Immunotherapy of Cancer|June 16, 2023
Selective immune suppression using interleukin-6 receptor inhibitors for management of immune-related adverse eventsFaisal Fa'ak, Maryam Buni, Adewunmi Falohun, et al.
Pageof 2